Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study
Background: Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of women do not adhere to AET. We developed SOIE, a one-year program designed to enhance the AET experience and adherence....
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/1/45 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588712994668544 |
|---|---|
| author | Véronique Turcotte Laurence Guillaumie Martine Lemay Anne Dionne Julie Lemieux Angéline Labbé Carolyn Gotay Line Guénette Sophie Lauzier |
| author_facet | Véronique Turcotte Laurence Guillaumie Martine Lemay Anne Dionne Julie Lemieux Angéline Labbé Carolyn Gotay Line Guénette Sophie Lauzier |
| author_sort | Véronique Turcotte |
| collection | DOAJ |
| description | Background: Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of women do not adhere to AET. We developed SOIE, a one-year program designed to enhance the AET experience and adherence. SOIE was pilot-tested in a mixed-methods randomized controlled trial. This report presents the experience of women and healthcare providers (HCPs) with SOIE. Methods: A descriptive qualitative study using semi-structured interviews and thematic analysis was conducted with 20 women and 7 HCPs who participated in the program. Results: Most women and HCPs reported high satisfaction with the program. Women felt it addressed their need for information and strategies to manage side effects. They felt supported and developed a more positive attitude toward AET, which contributed to their intention to pursue AET. They perceived that the program helped them navigate the AET experience and reduced their stress or fear regarding AET. HCPs corroborated these benefits. Conclusions: Findings suggest that SOIE can enhance the experience and motivation to pursue the AET treatment by meeting important needs for information, side-effects management, and psycho-emotional support. Programs like SOIE can have benefits beyond adherence by improving patients’ well-being during this crucial long-term treatment. |
| format | Article |
| id | doaj-art-939b01906cca43088596a9b5d22561f7 |
| institution | Kabale University |
| issn | 1198-0052 1718-7729 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Current Oncology |
| spelling | doaj-art-939b01906cca43088596a9b5d22561f72025-01-24T13:28:28ZengMDPI AGCurrent Oncology1198-00521718-77292025-01-013214510.3390/curroncol32010045Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative StudyVéronique Turcotte0Laurence Guillaumie1Martine Lemay2Anne Dionne3Julie Lemieux4Angéline Labbé5Carolyn Gotay6Line Guénette7Sophie Lauzier8Population Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaPopulation Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaCentre des Maladies du Sein, CHU de Québec-Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaCentre des Maladies du Sein, CHU de Québec-Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaCentre des Maladies du Sein, CHU de Québec-Université Laval, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaCentre Interdisciplinaire De Recherche en Réadaptation Et Intégration Sociale (CIRRIS), 525 Boulevard Wilfrid-Hamel, Québec, QC G1M 2S8, CanadaSchool of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, BC V6T 1Z3, CanadaPopulation Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaPopulation Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Hôpital du Saint-Sacrement, 1050 Chemin Ste-Foy, Québec, QC G1S 4L8, CanadaBackground: Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of women do not adhere to AET. We developed SOIE, a one-year program designed to enhance the AET experience and adherence. SOIE was pilot-tested in a mixed-methods randomized controlled trial. This report presents the experience of women and healthcare providers (HCPs) with SOIE. Methods: A descriptive qualitative study using semi-structured interviews and thematic analysis was conducted with 20 women and 7 HCPs who participated in the program. Results: Most women and HCPs reported high satisfaction with the program. Women felt it addressed their need for information and strategies to manage side effects. They felt supported and developed a more positive attitude toward AET, which contributed to their intention to pursue AET. They perceived that the program helped them navigate the AET experience and reduced their stress or fear regarding AET. HCPs corroborated these benefits. Conclusions: Findings suggest that SOIE can enhance the experience and motivation to pursue the AET treatment by meeting important needs for information, side-effects management, and psycho-emotional support. Programs like SOIE can have benefits beyond adherence by improving patients’ well-being during this crucial long-term treatment.https://www.mdpi.com/1718-7729/32/1/45aromatase inhibitorsbreast neoplasmsmedication adherencepilot studyqualitative researchrandomized clinical trial |
| spellingShingle | Véronique Turcotte Laurence Guillaumie Martine Lemay Anne Dionne Julie Lemieux Angéline Labbé Carolyn Gotay Line Guénette Sophie Lauzier Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study Current Oncology aromatase inhibitors breast neoplasms medication adherence pilot study qualitative research randomized clinical trial |
| title | Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study |
| title_full | Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study |
| title_fullStr | Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study |
| title_full_unstemmed | Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study |
| title_short | Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study |
| title_sort | perspectives of women with breast cancer and healthcare providers participating in an adherence enhancing program for adjuvant endocrine therapy a qualitative study |
| topic | aromatase inhibitors breast neoplasms medication adherence pilot study qualitative research randomized clinical trial |
| url | https://www.mdpi.com/1718-7729/32/1/45 |
| work_keys_str_mv | AT veroniqueturcotte perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT laurenceguillaumie perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT martinelemay perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT annedionne perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT julielemieux perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT angelinelabbe perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT carolyngotay perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT lineguenette perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy AT sophielauzier perspectivesofwomenwithbreastcancerandhealthcareprovidersparticipatinginanadherenceenhancingprogramforadjuvantendocrinetherapyaqualitativestudy |